Explore the latest developments concerning Blood pressure medication.
Blood pressure medication recalled nationwide over possible metal contamination
Recalls occur when manufacturers and distributors remove products “that present a risk of injury or gross deception or are otherwise defective,” according to the FDA.
Check your medicine cabinets: A new nationwide recall has been issued for some pills typically used to treat high blood pressure because they may be contaminated with metal.
Breckenridge Pharmaceutical, Inc. issued the voluntary recall Monday for one lot of Propranolol Hydrochloride Extended-Release Capsules. The 60 mg white capsules are manufactured by Adare Pharma and could potentially contain pieces of metal.
The pills could potentially cause "lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine," the announcement said. To date, the company said it was not aware of any adverse health events related to the recall.
Breckenridge Pharmaceutical, Inc. Issues Voluntary Nationwide Consumer-Level Recall of One Lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, Due to Potential Metal Contamination
BERKELEY HEIGHTS, N.J., Nov. 16, 2026 /PRNewswire/ — Breckenridge Pharmaceutical, Inc. (Breckenridge) is voluntarily recalling to the consumer level one lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, manufactured by Adare Pharma Solutions, due to potential metal contamination.
Use of product from the affected lot could potentially cause lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine. The affected lot shared intermediate material suspected to be the source of metal contamination identified in a separate lot that was not released to market. To date, Breckenridge is not aware of any adverse events assessed to be related to this recall. Product from the affected lot subject to this recall was distributed nationwide to wholesalers and pharmacies between October 26, 2026 and November 04, 2026.
Vocabulary Builder – Learning: Master 19000+ English words with Tinder-style swipe learning, 4 quiz types, and smart spaced repetition. GRE, TOEFL, IELTS & SAT prep included!
Blood pressure medication recalled over ‘foreign tablets’
A New Jersey-based drug company is recalling thousands of bottles of a high blood pressure and heart drug due to the presence of foreign tablets or capsules in the product, according to a notice published by the Food and Drug Administration last week.
Advagen Pharma Limited is recalling 3,684 bottles of metoprolol tartrate tablets, USP, in 50-milligram doses, the notice said. Each bottle holds 1,000 tablets, it added.
The reason for the recall, it said, is because of the “presence of foreign tablets/capsules” in the product. The notice did not provide more details about the contamination.
The batch number for the recalled medication is 2611C065A1, and it has an expiration date of May 2028. The tablets were distributed around the United States.
For more detailed information, explore updates concerning Blood pressure medication.





















0 Comments